Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, Jap
NCT02131662
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
309
Enrollment
INDUSTRY
Sponsor class
Conditions
Leiomyoma
Interventions
DRUG:
BAY1002670
DRUG:
BAY1002670
DRUG:
BAY1002670
DRUG:
BAY1002670
DRUG:
Placebo
Sponsor
Bayer